Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


legal lawyer options about drugrisk


No Januvia Recall

januvia recall warningsThe prescription drug Januvia was released in 2006 by Merck & Co. to help people dealing with diabetes control their blood sugar levels. Despite its high cost, it has been used by millions of patients in over 80 countries.

Unfortunately, drug safety experts have warned that diabetes medications like Januvia may have a link to pancreatic cancer and thyroid cancer. So far, there hasn’t been a Januvia recall. However, lawyers are helping those affected by cancer from Januvia seek compensation.

Januvia helps control blood-sugar levels in those with diabetes by inhibiting the enzyme DPP-4, which in turn increases insulin production and the absorption of sugar from the blood. However, since studies have shown DPP-4 may also prevent the spread of cancerous cells, Januvia may reduce the body’s natural protection against cancer.

Pancreatic cancer attacks the lining of the pancreas. It can spread quickly and is a leading cause of cancer death. Thyroid cancer is often less severe but still may require surgery and ongoing treatment.

Although the FDA has not issued a Januvia recall, they have cautioned about the relation to pancreatitis and pancreatic cancer. Since Merck has delayed important safety testing and has failed to properly warn patients, they face liability for the damages.

If you or a loved one have been diagnosed with thyroid cancer or pancreatic cancer after taking Januvia, it is important to speak with a lawyer about your legal rights. You may be entitled to substantial compensation. Contact us today.

The FDA advised consumers in 2009 and 2013 that diabetes drugs like Januvia may be linked to pancreatitis, which can lead to pancreatic cancer. Although they required additional label warnings, they did not issue a Januvia recall or restrict its use.

In 2011, researchers from the University of California at Los Angeles published a study that found Januvia could increase the risk of pancreatitis by 6 times the normal rate, and the risk of pancreatic cancer and thyroid cancer by 270% and 148%, respectively.

Although the FDA ordered Merck to conduct a new study over the risks, a notice of violation in February of 2012 shows the company delayed the testing.

Most recently, the Journal for the American Medical Association published a study in February of 2013 that found diabetes drugs like Januvia could double the risk of pancreatitis, which can lead to pancreatic cancer and kidney failure.

If you or a family member have been affected by pancreatic cancer or thyroid cancer, it is important to learn your legal options. Although a Januvia recall has not been issued, a lawyer can let you know what compensation is available and how long you have to take action.

Due to the complexity of defective drug injury lawsuits, it is important to choose a lawyer with experience in this type of case. DrugRisk only recommends lawyers and law firms that have already handled diabetes drug cancer or Januvia lawsuits.

Contact us today for more information on the warnings, research, side effects and legal news related to Januvia and other diabetes drugs, or to speak with a lawyer. We are available 24 hours a day to help.